2 completed, 1 recruiting, 1 terminated, 1 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 2, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
Follow ivacaftor: new trials by email Literature Review of ivacaftor trials Research Report on ivacaftor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Elexacaftor, Tezacaftor, Ivacaftor, Ivacaftor (VX-770) - Cystic Fibrosis (CF) | Phase 4 | Recruiting | Istituto Giannina Gaslini | 50 | 2026-09-18 | 2026-10-14 |
| Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis Trikafta - Non-cystic Fibrosis Bronchiectasis | Phase 4 | Completed | Emory University | 32 | 2023-04-18 | 2026-02-09 |
| VX-770 for the Treatment of Chronic Bronchitis Ivacaftor (VX-770) - Chronic Bronchitis | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2020-01-01 | 2022-02-17 | |
| Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations Symdeko, Ivacaftor and Symdeko - Cystic Fibrosis | Phase 4 | Terminated | University of Alabama at Birmingham | 1 | 2018-12-01 | 2025-04-16 |
| Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations Ivacaftor/Ataluren - Cystic Fibrosis | Phase 4 | Completed | University of Alabama at Birmingham | 1 | 2017-03-17 | 2019-07-19 |
| CPET in CF Patients With One G551D Mutation Taking VX770 ivacaftor, placebo - Cystic Fibrosis | Phase 4 | Unknown | The Alfred | 20 | 2014-02-01 | 2016-07-25 |
Cystic Fibrosis (4) · Bronchitis, Chronic (1)
University of Alabama at Birmingham (3) · Emory University (1) · Istituto Giannina Gaslini (1) · The Alfred (1)
United States (4) · Australia (1) · Italy (1)
Eric Sorscher, MD (1) · John Wilson (1) · Steven M Rowe, MD (1)